VIRX Market Cap History Table | ||||||||||||||||||||||||||||
Also see: VIRX Shares Outstanding History and VIRX YTD Return |
VIRX Market Cap History Table | ||||||||||||||||||||||||||||
Also see: VIRX Shares Outstanding History and VIRX YTD Return |
VIRX Market Cap History Chart | |||||||||||||||||||||||||||||
-57.77% CAGR Mouse over chart for data details
|
VIRX Stock Price Chart |
About Viracta Therapeutics Inc |
Viracta Therapeutics is a precision oncology company focused on the development of medicines targeting virus-associated malignancies. Co.'s main program is focused on cancers associated with the Epstein-Barr virus (EBV). Co.'s main product candidate is an all-oral combination therapy of its investigational drug, nanatinostat and the antiviral agent valganciclovir (collectively referred to as Nana-val). Nana-val is being investigated in clinical trials, including NAVAL-1, a trial for the treatment of multiple subtypes of relapsed/refractory EBV-positive (EBV+) lymphoma, as well as a trial for the treatment of EBV+ recurrent or metastatic nasopharyngeal carcinoma and other EBV+ solid tumors. We show 13 historical shares outstanding datapoints in our VIRX shares outstanding history coverage, used to compute VIRX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing VIRX market cap history over the course of time is important for investors interested in comparing VIRX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of VIRX versus a peer is one thing; comparing VIRX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like VIRX can fluctuate over the course of history. With this page we aim to empower investors researching VIRX by allowing them to research the VIRX market cap history. |
VIRX Current Stock Quote |
Free VIRX Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
VIRX Share Performance |
Market Cap Peers |
Viracta Therapeutics (VIRX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
VIVE Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.